Taysha Gene Therapies, Inc. (TSHA)
NASDAQ·Healthcare·Biotechnology
$6.34
+8.29%
Mkt Cap $1.35B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$11.80
Range $11.00 – $13.00
Implied Upside
+86.3%
Consensus $11.80 vs current $6.34
NASDAQ·Healthcare·Biotechnology
$6.34
+8.29%
Mkt Cap $1.35B
Buy
6
Hold
0
Sell
0
Price Target (15 analysts)
$11.80
Range $11.00 – $13.00
+86.3%
Consensus $11.80 vs current $6.34